Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapy.
Noh MH, Kang JM, Miller AA, Nguyen G, Huang M, Shim JS, Bueso-Perez AJ, Murphy SA, Rivera-Caraballo KA, Otani Y, Kim E, Yoo SH, Yan Y, Banasavadi-Siddegowda Y, Nakashima H, Chiocca EA, Kaur B, Zhao Z, Lee TJ, Yoo JY.
Noh MH, et al. Among authors: chiocca ea.
Neuro Oncol. 2024 Sep 5;26(9):1602-1616. doi: 10.1093/neuonc/noae105.
Neuro Oncol. 2024.
PMID: 38853689
Free PMC article.
Clinical Trial.